Rate of decline of lung function in asbestosis

C. E. Bryant, D. H. Bryant (Sydney, Darlinghurst, Australia)

Source: Annual Congress 2004 - Pneumoconiosis: from asbestos to popcorn
Session: Pneumoconiosis: from asbestos to popcorn
Session type: Oral Presentation
Number: 3010

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. E. Bryant, D. H. Bryant (Sydney, Darlinghurst, Australia). Rate of decline of lung function in asbestosis. Eur Respir J 2004; 24: Suppl. 48, 3010

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung function decline in patients with bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018

Lung function decline in asthma
Source: Eur Respir J 2007; 30: 411-413
Year: 2007


Artificial stone associated silicosis with rapid lung function decline
Source: International Congress 2017 – Silicosis has not gone away
Year: 2017




Distribution of CT-quantified emphysema: Association with lung function decline
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011


Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014


Lung hyperinflation is a determinant of the heart rate recovery delay in COPD patients
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017

Predictors of lung function deterioration in COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


The relation of six-minute walk test and lung function in interstitial lung disease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Lung function predicts lung cancer
Source: Eur Respir J 2010; 35: 1421-1422
Year: 2010


Predictors of accelerated decline in lung function in adult-onset asthma
Source: Eur Respir J, 51 (2) 1701785; 10.1183/13993003.01785-2017
Year: 2018



Estimating lung function decline and the effect of smoking in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 578s
Year: 2002

Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014

Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes
Source: Eur Respir J 2003; 22: Suppl. 45, 278s
Year: 2003

Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 278s
Year: 2006

Lack of sex difference in lung function decline in emphysema
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Lung function measurements versus structural lung disease in CF
Source: Breathe 2008; 5: 65
Year: 2008

Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015